Document Details

FieryComprehension3097

Uploaded by FieryComprehension3097

Palawan State University

Peter J. Kennelly & Victor W. Rodwell

Tags

enzymes biochemistry mechanism of action biological processes

Summary

This chapter discusses enzymes, their mechanisms of action, and their roles in biological processes. It covers the structural relationships between vitamins and coenzymes, and the mechanistic strategies employed by enzymes for catalyzing reactions. The chapter also explores enzyme-linked immunoassays, the role of restriction enzymes, and site-directed mutagenesis.

Full Transcript

C H A P T E R Enzymes: Mechanism of Action Peter J. Kennelly, PhD, & Victor W. Rodwell, PhD...

C H A P T E R Enzymes: Mechanism of Action Peter J. Kennelly, PhD, & Victor W. Rodwell, PhD 7 OBJ E C TI VE S Describe the structural relationships between specific B vitamins and certain coenzymes. After studying this chapter, Outline the four principal mechanistic strategies employed by enzymes to you should be able to: catalyze chemical reactions. Explain the concepts of the “lock and key” and “induced fit” models for enzyme– substrate interaction and how the latter accounts for the dynamic nature of enzyme catalysis. Outline the underlying principles of enzyme-linked immunoassays. Describe how detecting and measuring the activity of many enzymes can be facilitated by coupling with an appropriate dehydrogenase. Identify proteins whose plasma levels are used as biomarkers for diagnosis and prognosis. Describe the application of restriction endonucleases and of restriction fragment length polymorphisms in the detection of genetic diseases. Illustrate the utility of site-directed mutagenesis for the identification of aminoacyl residues that are involved in the recognition of substrates or allosteric effectors, or in the mechanism of catalysis. Describe how “affinity tags” can facilitate purification of a protein expressed from its cloned gene. Discuss the events that led to the discovery that RNAs can act as enzymes, and briefly describe the evolutionary concept of an “RNA world.” BIOMEDICAL IMPORTANCE of key enzymes that resut from genetic efects, nutritiona eficits, tissue amage, toxins, or infection by vira or bacteria Nobe aureate (1946) James Sumner efine an enzyme as pathogens (eg, Vibrio cholerae). Thus, the abiity to etect an “a catayst of high moecuar weight an bioogica origin.” to quantify the activity of specific enzymes in boo, other tissue Enzymes catayze the chemica reactions that make ife on fuis, or ce extracts provies information that enhances the the earth possibe, such as the breakown of nutrients to sup- physician’s abiity to iagnose many iseases. py energy an biomoecuar buiing bocks; the assemby In aition to serving as the cataysts for a metaboic pro- of those buiing bocks into proteins, DNA, membranes, cesses, the impressive cataytic activity an substrate specificity ces, an tissues; an the harnessing of energy to power ce of enzymes enabes them to fufi unique roes in human heath motiity, neura function, an musce contraction. Amost a an we-being. The protease rennin, for exampe, is utiize in enzymes are proteins. Notabe exceptions incue ribosoma the prouction of cheeses, whie actase is empoye to remove RNAs an a hanfu of RNA moecues imbue with eno- actose from mik to benefit actose-intoerant iniviuas. nucease or nuceotie igase activity known coectivey as Proteases an amyases augment the capacity of etergents to ribozymes. Many pathoogic conitions are the irect conse- remove irt an stains, whie other enzymes can participate in quence of changes in the quantity or in the cataytic activity the stereospecific synthesis of compex rugs or antibiotics. 59 60 SECTION II Enzymes: Kinetics, Mechanism, Regulation, & Role of Transition Metals 4 inicating the particuar substrate on which the enzyme acts (xanthine oxiase), its source (pancreatic ribonucease), its moe of reguation (hormone-sensitive ipase), or a charac- 1 1 3 teristic feature of its mechanism of action (cysteine protease). Where neee, aphanumeric esignators can be ae to 3 ientify mutipe forms, or isozymes, of an enzyme (eg, RNA 2 poymerase III; protein kinase Cβ). 2 As more enzymes were iscovere, these eary naming Enzyme site Substrate conventions increasingy resute in the inavertent esigna- tion of some enzymes by mutipe names or the assignment of FIGURE 7–1 Planar representation of the “three-point upicate names to enzymes exhibiting simiar cataytic capa- attachment” of a substrate to the active site of an enzyme. biities. To aress these probems, the Internationa Union of Although atoms 1 and 4 are identical, once atoms 2 and 3 are bound to their complementary sites on the enzyme, only atom 1 can bind. Biochemistry (IUB) eveope a system of enzyme nomen- Once bound to an enzyme, apparently identical atoms thus may be cature in which each enzyme has a unique name an coe distinguishable, permitting a stereospecific chemical change. number that ientify the type of reaction catayze an the substrates invove. Enzymes are groupe into the foowing six casses: ENZYMES ARE EFFICIENT & 1. Oxidoreductases—enzymes that catayze oxiations an HIGHLY SPECIFIC CATALYSTS reuctions The enzymes that catayze the conversion of one or more com- 2. Transferases—enzymes that catayze transfer of moieties pouns (substrates) into one or more ifferent compouns such as gycosy, methy, or phosphory groups (products) generay enhance the rates of the corresponing noncatayze reaction by factors of 106 to 109 or even more. 3. Hydrolases—enzymes that catayze hydrolytic ceavage of Athough some enzymes become moifie uring cataysis, C—C, C—O, C—N, an other covaent bons these transient aterations are resove in the course of the 4. Lyases—enzymes that catayze ceavage of C—C, C—O, reaction being catayze. In aition to being highy efficient, C—N, an other covaent bons by atom elimination, gen- enzymes are aso extremey selective. Typicay, the cataysts erating oube bons use in synthetic chemistry are specific for the type of reac- tion catayze an wi act on any compoun containing the 5. Isomerases—enzymes that catayze geometric or structura reevant functiona group. Enzymes, however, are generay changes within a moecue specific for a singe substrate or even a singe stereoisomer 6. Ligases—enzymes that catayze the joining together (igation) thereof—for exampe, d- but not l-sugars, l- but not d-amino of two moecues in reactions coupe to the hyroysis of ATP acis—or a sma set of cosey reate substrates. Since they bin substrates through at east “three points of attachment” The IUB name of hexokinase is ATP:D-hexose 6- (Figure 7–1), enzymes aso can prouce chira proucts from phosphotransferase E.C. 2.7.1.1. This name ientifies hexoki- nonchira substrates. For exampe, reuction of the nonchira nase as a member of cass 2 (transferases), subcass 7 (transfer substrate pyruvate by actate ehyrogenase prouces excu- of a phosphory group), sub-subcass 1 (acoho is the phos- sivey l-actate, not a racemic mixture of d- an l-actate. The phory acceptor), an “hexose-6” inicates that the acoho exquisite specificity of enzyme cataysts imbues iving ces phosphoryate is on carbon six of a hexose. Whie EC num- with the abiity to simutaneousy conuct an inepenenty bers have proven particuary usefu to ifferentiate enzymes contro a broa spectrum of biochemica processes. with simiar functions or simiar cataytic activities, IUB names ten to be engthy an cumbersome. Consequenty, hexokinase an many other enzymes commony are referre ENZYMES ARE CLASSIFIED BY to using their traitiona, abeit sometimes ambiguous names. REACTION TYPE Some of the names for enzymes first escribe in the eari- PROSTHETIC GROUPS, est ays of biochemistry persist in use to this ay. Exampes COFACTORS, & COENZYMES PLAY incue pepsin, trypsin, an amyase. Eary biochemists gener- ay name newy iscovere enzymes by aing the suffix –ase IMPORTANT ROLES IN CATALYSIS to a escriptor for the type of reaction catayze. For exampe, Many enzymes contain sma moecues or meta ions that par- enzymes that remove the eements of hyrogen, H2 or H− ticipate irecty in substrate bining or in cataysis. Terme pus H+, generay are referre to as ehyrogenases, enzymes prosthetic groups, cofactors, an coenzymes, they exten the that hyroyze proteins as proteases, an enzymes that cata- repertoire of mechanistic capabiities beyon those affore yze rearrangements in configuration as isomerases. In many by the functiona groups present on the aminoacy sie chains cases, these genera escriptors were suppemente with terms of pepties. CHAPTER 7 Enzymes: Mechanism of Action 61 Prosthetic Groups O Prosthetic groups are tighty an staby incorporate into a NH2 protein’s structure by covaent bons or noncovaent forces. + N Exampes incue pyrioxa phosphate, favin mononuceo- tie (FMN), favin aenine inuceotie (FAD), thiamin pyro- O CH2 phosphate, ipoic aci, biotin, an transition metas such as Fe, O Co, Cu, Mg, Mn, an Zn. Meta ions that participate in reox reactions generay are boun as organometaic compexes H H such as the prosthetic groups heme or iron–sufur custers (see HO OH O P O– Chapter 10). Metas may faciitate the bining an orientation of substrates, the formation of covaent bons with reaction NH2 intermeiates (Co2+ in coenzyme B12, see Chapter 44), or by N acting as Lewis acis or bases to rener substrates more elec- N trophilic (eectron-poor) or nucleophilic (eectron-rich), an O N N hence more reactive (see Chapter 10). O P O CH2 Cofactors Associate Reversibly With O – O Enzymes or Substrates H H Cofactors serve functions simiar to those of prosthetic groups HO OR an overap with them. The major ifference between the two is operationa, not chemica. Cofactors bin weaky an tran- FIGURE 7–2 Structure of NAD+ and NADP+. For NAD+, OR = sienty to their cognate enzymes or substrates, forming is- —OH. For NADP+, —OR = —OPO32–. sociabe compexes. Therefore, unike associate prosthetic groups, cofactors must be present in the surrouning environ- permeate ces. Secon, they increase the number of points of ment to promote compex formation in orer for cataysis to contact between substrate an enzyme, which increases the occur. Meta ions form the most numerous cass of cofactors. affinity an specificity with which sma chemica groups such Enzymes that require a meta ion cofactor are terme metal- as acetate (coenzyme A), gucose (UDP), or hyrie (NAD+) activated enzymes to istinguish them from the metalloen- are boun by their target enzymes. Other chemica moieties zymes for which boun meta ions serve as prosthetic groups. transporte by coenzymes incue methy groups (foates) an It is estimate that one-thir of a enzymes fa into one of oigosaccharies (oicho). these two groups. Many Coenzymes, Cofactors, CATALYSIS OCCURS AT & Prosthetic Groups Are Derivatives THE ACTIVE SITE of B Vitamins An important eary 20th-century insight into enzymic catay- sis sprang from the observation that the presence of substrates The water-soube B vitamins suppy important components reners enzymes more resistant to the enaturing effects of of numerous coenzymes. Nicotinamide is a component of the eevate temperatures. This observation e Emi Fischer to reox coenzymes NAD an NADP (Figure 7–2); riboflavin propose that enzymes (E) an their substrates (S) form an is a component of the reox coenzymes FMN an FAD; pan- enzyme–substrate (ES) compex whose therma stabiity is tothenic acid is a component of the acy group carrier coen- greater than that of the enzyme itsef. This insight profouny zyme A. As its pyrophosphate thiamin participates in the shape our unerstaning of both the chemica nature an ecarboxyation of α-keto acis whie foic aci an cobamie kinetic behavior of enzymic cataysis. coenzymes function in one-carbon metaboism. In aition, Fischer reasone that the exquisitey high specificity with severa coenzymes contain the aenine, ribose, an phosphory which enzymes iscriminate their substrates when forming an moieties of AMP or ADP (see Figure 7–2). ES compex was anaogous to the manner in which a mechani- ca ock istinguishes the proper key. The anaogy to enzymes is Coenzymes Serve as Substrate Shuttles that the “ock” is forme by a surface-accessibe ceft or pocket Coenzymes serve as recycabe shuttes that transport many in the enzyme cae the active site (see Figures 5–6 an 5–8). substrates from one point within the ce to another. The func- As impie by the ajective “active,” the active site is much tion of these shuttes is twofo. First, they stabiize species more than simpy a recognition site for bining substrates; it such as hyrogen atoms (FADH2) or hyrie ions (NADH) provies the environment wherein chemica transformation that are too reactive to persist for any significant time in the takes pace. Within the active site, substrates are brought into presence of the water, oxygen, or the organic moecues that cose proximity with one another in optima aignment with 62 SECTION II Enzymes: Kinetics, Mechanism, Regulation, & Role of Transition Metals Arg 145 Acid–Base Catalysis NH In aition to contributing to the abiity of the active site to OH + NH2 C NH2 bin substrates, the ionizabe functiona groups of aminoacy sie chains an, where present, of prosthetic groups, can con- O tribute to cataysis by acting as acis or bases. We istinguish H H C O O two types of aci–base cataysis. Specific acid or base cataly- N H C C sis refers to reactions for which the ony participating acis N H Tyr 248 H or bases are protons or hyroxie ions. The rate of reaction N C His 196 CH2 thus is sensitive to changes in the concentration of protons O Zn2+ or hyroxie ions, but is independent of the concentrations of NH2 O O other acis (proton onors) or bases (proton acceptors) pres- His 69 C N ent in the soution or at the active site. Reactions whose rates Glu 72 are responsive to all the acis or bases present are sai to be N subject to general acid catalysis or general base catalysis. H FIGURE 7–3 Two-dimensional representation of a dipeptide Catalysis by Strain substrate, glycyl-tyrosine, bound within the active site of For cataysis of ytic reactions, which invove breaking a covaent carboxypeptidase A. bon, enzymes typicay bin their substrates in a conforma- tion that weakens the bon targete for ceavage through physica the cofactors, prosthetic groups, an aminoacy sie chains istortion an eectronic poarization. This straine conforma- that participate in catayzing the transformation of substrates tion mimics that of the transition state intermediate, a transient into proucts (Figure 7–3). Cataysis is further enhance by species that represents the miway point in the transformation the capacity of the active site to shie substrates from water of substrates to proucts. Nobe Laureate Linus Pauing was the an generate an environment whose poarity, hyrophobicity, first to suggest a roe for transition state stabilization as a aciity, or akainity can iffer markey from that of the sur- genera mechanism by which enzymes acceerate the rates of rouning cytopasm. chemica reactions. Knowege of the transition state of an enzyme-catayze reaction is frequenty expoite by chem- ists to esign an synthesize more effective enzyme inhibitors, ENZYMES EMPLOY MULTIPLE cae transition state analogs, as potentia pharmacophores. MECHANISTIC STRATEGIES TO FACILITATE CATALYSIS Covalent Catalysis The process of covalent catalysis invoves the formation of a Enzymes use combinations of four genera mechanistic strate- covaent bon between the enzyme an one or more substrates. gies to achieve ramatic enhancements of the rates of chemica The modified enzyme thus becomes a reactant. Covaent reactions. cataysis provies a new reaction pathway whose activation energy is ower—an rate of reaction therefore faster—than Catalysis by Proximity the pathways avaiabe in homogeneous soution. The chemi- In orer to chemicay interact, substrate moecues must come cay moifie state of the enzyme is, however, transient. within bon-forming istance of one another. The higher Competion of the reaction returns the enzyme to its origi- their concentration, the more frequenty they wi encounter na, unmoifie state. Its roe thus remains cataytic. Covaent one another, an the greater wi be the rate at which reaction cataysis is particuary common among enzymes that catayze proucts appear. When an enzyme bins substrate moecues group transfer reactions. Resiues on the enzyme that par- at its active site, it creates a region of high oca substrate con- ticipate in covaent cataysis generay are cysteine or serine, centration, one in which they are oriente in an iea position an occasionay histiine. Covaent cataysis often foows a to chemicay interact. In an of itsef, this proximity resuts “ping-pong” mechanism—one in which the first substrate is in rate enhancements of at east a 1000-fo over that observe in boun an its prouct reease prior to the bining of the the absence of an enzyme. secon substrate (Figure 7–4). Pyr Glu Ala CHO CH2NH2 KG CH2NH2 CHO E CHO E E E CH2NH2 E E E CHO Ala Pyr KG Glu FIGURE 7–4 “Ping-pong” mechanism for transamination. E—CHO and E—CH2NH2 represent the enzyme-pyridoxal phosphate and enzyme-pyridoxamine complexes, respectively. (Ala, alanine; Glu, glutamate; KG, α-ketoglutarate; Pyr, pyruvate.) CHAPTER 7 Enzymes: Mechanism of Action 63 O A B N.. C R H H.... O 1 H O O H O O C C A B CH2 CH2 Asp Y Asp X O N.. C R A B 2 H OH H H O O O O C C FIGURE 7–5 Two-dimensional representation of Koshland’s induced fit model of the active site of a lyase. Binding of the sub- CH2 CH2 strate A—B induces conformational changes in the enzyme that align Asp Y Asp X catalytic residues which participate in catalysis and strain the bond O between A and B, facilitating its cleavage. N H C R H HO SUBSTRATES INDUCE CONFORMATIONAL CHANGES 3 O O H O O IN ENZYMES C C Whie Fischer’s “ock an key moe” accounte for the exqui- CH2 CH2 site specificity of enzyme–substrate interactions, the impie Asp Y Asp X rigiity of the enzyme’s active site faie to account for the ynamic changes that accompany cataytic transformations. FIGURE 7–6 Mechanism for catalysis by an aspartic protease This rawback was aresse by Danie Koshan’s induced such as HIV protease. Curved arrows indicate directions of electron fit model, which states that as substrates bin to an enzyme, movement. ➀ Aspartate X acts as a base to activate a water molecule by abstracting a proton. ➁ The activated water molecule attacks they inuce a conformationa change that is anaogous to pac- the peptide bond, forming a transient tetrahedral intermediate. ing a han (substrate) into a gove (enzyme) (Figure 7–5). The ➂ Aspartate Y acts as an acid to facilitate breakdown of the tetra- enzyme in turn inuces reciproca changes in its substrates, hedral intermediate and release of the split products by donating a harnessing the energy of bining to faciitate the transfor- proton to the newly formed amino group. Subsequent shuttling of the mation of substrates into proucts. The inuce fit moe proton on Asp X to Asp Y restores the protease to its initial state. has been ampy confirme by biophysica stuies of enzyme motion uring substrate bining. then faciitates the ecomposition of this tetrahera inter- meiate by onating a proton to the amino group prouce by rupture of the peptie bon. The two active site aspartates HIV PROTEASE ILLUSTRATES can act simutaneousy as a genera base or as a genera aci ACID–BASE CATALYSIS because their immeiate environment favors ionization of one, but not the other. Enzymes of the aspartic protease family, which incues the igestive enzyme pepsin, the ysosoma cathepsins, an the protease prouce by the human immunoeficiency virus CHYMOTRYPSIN & FRUCTOSE-2, (HIV), share a common mechanism that empoys two con- serve asparty resiues as aci–base cataysts. In the first 6-BISPHOSPHATASE ILLUSTRATE stage of the reaction, one aspartate functions as a genera base COVALENT CATALYSIS (Asp X, Figure 7–6) that extracts a proton from a water mo- ecue to make it more nuceophiic. The resuting nuceophie Chymotrypsin then attacks the eectrophiic carbony carbon of the peptie Whie cataysis by aspartic proteases invoves the irect hyro- bon targete for hyroysis, forming a tetrahedral transition ytic attack of water on a peptie bon, cataysis by the ser- state intermediate. A secon aspartate (Asp Y, Figure 7–6) ine protease chymotrypsin invoves formation of a covaent 64 SECTION II Enzymes: Kinetics, Mechanism, Regulation, & Role of Transition Metals acy-enzyme intermeiate. A conserve sery resiue, serine H O 195 in the bovine form, is activate via interactions with his- R1 N C R2 tiine 57 an aspartate 102. Whie these three resiues are far apart in primary structure, in the active site of the mature, 1 O O H N N H O foe protein they resie within bon-forming istance of C Ser 195 one another. Aigne in the orer Asp 102-His 57-Ser 195, Asp 102 His 57 this trio forms a inke charge-relay network that acts as a “proton shuttle.” H O Bining of substrate initiates proton shifts that in R1 N C R2 effect transfer the hyroxy proton of Ser 195 to Asp 102 (Figure 7–7). The enhance nuceophiicity of the sery oxy- 2 O O H N N H O gen faciitates its attack on the carbony carbon of the peptie Ser 195 bon of the substrate, forming a covaent acyl-enzyme inter- Asp 102 His 57 mediate. The proton on Asp 102 then shuttes via His 57 to O the amino group iberate when the peptie bon is ceave. R1 NH2 C R2 The portion of the origina peptie with a free amino group then eaves the active site an is repace by a water moecue. 3 O O H N N O The charge-reay network now activates the water moecue by Ser 195 withrawing a proton through His 57 to Asp 102. The resut- Asp 102 His 57 ing hyroxie ion attacks the acy-enzyme intermeiate, an a O reverse proton shutte returns a proton to Ser 195, restoring its H C R2 origina state. Whie moifie uring the process of cataysis, O O chymotrypsin emerges unchange on competion of the reac- 4 O O H N N H Ser 195 tion. The proteases trypsin an eastase empoy a simiar cata- ytic mechanism, but the numbering of the resiues in their Asp 102 His 57 Ser-His-Asp proton shuttes iffer. O H Fructose-2,6-Bisphosphatase O C R2 Fructose-2,6-bisphosphatase, a reguatory enzyme of guco- 5 O O H N N H O neogenesis (see Chapter 19), catayzes the hyroytic reease Ser 195 of the phosphate on carbon 2 of fructose-2,6-bisphosphate. Asp 102 His 57 Figure 7–8 iustrates the roes of seven active site resiues. HOOC R2 Cataysis invoves a “cataytic tria” consisting of one Gu an two His resiues, of which one His forms a covaent phospho- 6 O O H N N H O histiy intermeiate. Ser 195 Asp 102 His 57 CATALYTIC RESIDUES ARE HIGHLY FIGURE 7–7 Catalysis by chymotrypsin. ➀ The charge-relay system removes a proton from Ser 195, making it a stronger nucleo- CONSERVED phile. ➁ Activated Ser 195 attacks the peptide bond, forming a Members of an enzyme famiy such as the aspartic or serine pro- transient tetrahedral intermediate. ➂ Release of the amino terminal teases empoy a simiar mechanism to catayze a common reac- peptide is facilitated by donation of a proton to the newly formed amino group by His 57 of the charge-relay system, yielding an acyl- tion type, but act on ifferent substrates. Most enzyme famiies Ser 195 intermediate. ➃ His 57 and Asp 102 collaborate to activate a appear to have arisen through gene upication events that cre- water molecule, which attacks the acyl-Ser 195, forming a second tet- ate a secon copy of the gene that encoes a particuar enzyme. rahedral intermediate. ➄ The charge-relay system donates a proton The two genes, an consequenty their encoe proteins, can to Ser 195, facilitating breakdown of the tetrahedral intermediate to then evove inepenenty, forming ivergent homologs that release the carboxyl terminal peptide ➅. recognize ifferent substrates. The resut is iustrate by chy- motrypsin, which ceaves peptie bons on the carboxy termi- ISOZYMES ARE DISTINCT ENZYME na sie of arge hyrophobic amino acis, an trypsin, which FORMS THAT CATALYZE THE ceaves peptie bons on the carboxy termina sie of basic amino acis. Proteins that iverge from a common ancestor are SAME REACTION sai to be homologous to one another. The common ancestry Higher organisms often eaborate severa physicay istinct of enzymes can be inferre from the presence of specific amino versions of a given enzyme, each of which catayzes the same acis in the same reative position in each famiy member. These reaction. These protein cataysts or isozymes can arise through resiues are sai to be evolutionarily conserved. gene upication or, in higher eukaryotes, aternative mRNA CHAPTER 7 Enzymes: Mechanism of Action 65 Assays of the cataytic activity of enzymes are frequenty use Lys 356 Lys 356 Arg Arg both in research an cinica aboratories. + 352 + 352 P + P + 6– 6– Single-Molecule Enzymology 2– 2– – O Arg 307 – O H+ Arg 307 The imite sensitivity of traitiona enzyme assays necessi- + Glu 327 + H P Glu 327 P tates the use of a arge group, or ensembe, of enzyme mo- + + His His ecues in orer to prouce measurabe quantities of prouct. 392 392 Arg 257 1 Arg 257 2 The ata obtaine thus refect the average activity of iniviua His 258 His 258 enzymes across mutipe cyces of cataysis. Recent avances in E Fru-2,6-P2 E-P Fru-6-P nanotechnology an imaging have mae it possibe to observe cataytic events invoving iscrete enzyme an substrate mo- Lys 356 Lys 356 ecues. Consequenty, scientists can now measure the rate of + Arg 352 + Arg 352 iniviua cataytic events, an sometimes a specific step in H + + cataysis, by a process cae single-molecule enzymology, an H O exampe of which is iustrate in Figure 7–9. Arg 307 Arg 307 – – + Pi + Glu 327 + H P + Glu 327 + + Drug Discovery Requires Enzyme His 392 His 392 Assays Suitable for High-Throughput 3 4 Arg 257 His 258 Arg 257 His 258 Screening E-P H2O E Pi Enzymes are frequent targets for the eveopment of rugs an other therapeutic agents. These generay take the form FIGURE 7–8 Catalysis by fructose-2,6-bisphosphatase. of enzyme inhibitors (see Chapter 8). The iscovery of new (1) Lys 356 and Arg 257, 307, and 352 stabilize the quadruple nega- tive charge of the substrate by charge–charge interactions. Glu 327 rugs is greaty faciitate when a arge number of potentia stabilizes the positive charge on His 392. (2) The nucleophile His 392 pharmacophores can be simutaneousy assaye in a rapi, attacks the C-2 phosphoryl group and transfers it to His 258, form- automate fashion—a process referre to as high-throughput ing a phosphoryl-enzyme intermediate. Fructose-6-phosphate now screening (HTS). HTS empoys robotics, optics, ata process- leaves the enzyme. (3) Nucleophilic attack by a water molecule, pos- ing, an microfuiics to simutaneousy conuct an monitor sibly assisted by Glu 327 acting as a base, forms inorganic phosphate. (4) Inorganic orthophosphate is released from Arg 257 and Arg 307. thousans of parae enzyme assays. It thus serves as a per- (Reproduced with permission from Pilkis SJ, Claus TH, Kurland IJ, et al: fect compement to combinatorial chemistry, a metho for 6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase: a metabolic signaling enzyme, Annu Rev Biochem. 1995;64:799-835.) spicing (see Chapter 36). Whie the homoogous proteases escribe act on ifferent substrates, isozymes aso may iffer in auxiiary features such as sensitivity to particuar reguatory factors (see Chapter 9) or subceuar ocation that aapt them to specific tissues or circumstances rather than istinct sub- strates. Isozymes that catayze the ientica reaction may aso enhance surviva by proviing a “backup” copy of an essentia enzyme. THE CATALYTIC ACTIVITY OF ENZYMES FACILITATES THEIR 1 2 3 4 DETECTION FIGURE 7–9 Direct observation of single DNA cleavage events catalyzed by a restriction endonuclease. DNA molecules The reativey sma quantities of enzymes typicay containe immobilized to beads (blue) are placed in a flowing stream of in ces hamper etermination of their presence an abun- buffer (black arrows), which causes them to assume an extended ance. However, the abiity to rapiy transform thousans of conformation. Cleavage at one of the restriction sites (orange) by an moecues of a specific substrate into proucts imbues each endonuclease leads to a shortening of the DNA molecule, which can enzyme with the abiity to ampify its presence. Uner appro- be observed directly in a microscope since the nucleotide bases in DNA are fluorescent. Although the endonuclease (red) does not fluo- priate conitions (see Chapter 8), the rate of the cataytic resce, and hence is invisible, the progressive manner in which the DNA reaction being monitore is proportionate to the amount of molecule is shortened (1→4) reveals that the endonuclease binds to enzyme present, which aows its concentration to be inferre. the free end of the DNA molecule and moves along it from site to site. 66 SECTION II Enzymes: Kinetics, Mechanism, Regulation, & Role of Transition Metals generating arge ibraries of chemica compouns spanning a prouce. Conversey, when a ehyrogenase catayzes the possibe combinations of a given set of chemica precursors. oxiation of NAD(P)H, a ecrease in absorbance at 340 nm wi be observe. In each case, the rate of change in absorbance Enzyme-Linked Immunoassays at 340 nm wi be proportionate to the quantity of the enzyme present. The sensitivity of enzyme assays can be expoite to etect The assay of enzymes whose reactions are not accompa- proteins that ack cataytic activity. Enzyme-linked immuno- nie by a change in absorbance or fuorescence is generay sorbent assays (ELISAs) use antiboies covaenty inke to more ifficut. In some instances, either the prouct or remain- a “reporter enzyme”, such as akaine phosphatase or horse- ing substrate can be transforme into a more reaiy etecte raish peroxiase, that can be use to prouce easiy-etecte compoun, athough the reaction prouct may have to be chromogenic or fuorescent proucts in vitro. Serum or other separate from unreacte substrate prior to measurement. bioogic sampes to be teste are first pace in mutiwe An aternative strategy is to evise a synthetic substrate whose microtiter pates. Most proteins ahere to the pastic surface prouct absorbs ight or fuoresces. For exampe, hyroysis of an thus are immobiize. Any expose pastic that remains is the phosphoester bon in p-nitropheny phosphate (pNPP), subsequenty “bocke” by aing a nonantigenic protein such an artificia substrate moecue, is catayze at a measurabe as bovine serum abumin. A soution of antiboy covaenty rate by numerous phosphatases, phosphoiesterases, an ser- inke to a reporter enzyme is then ae an the antiboies ine proteases. Whie pNPP oes not absorb visibe ight, the aowe to ahere to any immobiize antigen moecues. Excess anionic form of the p-nitropheno (pKa 6.7) generate on its free antiboy moecues are then remove by washing. The hyroysis strongy absorbs ight at 419 nm, an thus can be presence an quantity of boun antiboy is then etermine quantifie. by assaying the activity of the reporter enzyme, a quantity that shou be proportiona to the number of antiboy moecues present an, presumaby, the antigen moecues to which they Many Enzymes May Be Assayed by are boun. Coupling to a Dehydrogenase Another quite genera approach is to empoy a “coupe” assay NAD(P)+-Dependent Dehydrogenases (Figure 7–11). Typicay, a ehyrogenase whose substrate Are Assayed Spectrophotometrically is the prouct of the enzyme of interest is ae in cataytic excess. The rate of appearance or isappearance of NAD(P)H The physicochemica properties of the reactants in an then epens on the rate of the enzyme reaction to which the enzyme-catayze reaction ictate the options for the assay of ehyrogenase has been coupe. enzyme activity. Spectrophotometric assays expoit the abiity of a substrate or prouct to absorb ight. The reuce coen- zymes NADH an NADPH, written as NAD(P)H, absorb ight at a waveength of 340 nm, whereas their oxiize forms THE ANALYSIS OF CERTAIN NAD(P)+ o not (Figure 7–10). When NAD(P)+ is reuce, ENZYMES AIDS DIAGNOSIS the absorbance at 340 nm therefore increases in proportion The anaysis of enzymes in boo pasma pays a centra roe to—an at a rate etermine by—the quantity of NAD(P)H in the iagnosis of severa isease processes. Many enzymes are functiona constituents of boo. Exampes incue pseu- ochoinesterase, ipoprotein ipase, an components of the 1.0 Glucose 0.8 ATP, Mg2+ Hexokinase Optical density 0.6 ADP, Mg2+ Glucose-6-phosphate 0.4 NADP+ NADH Glucose-6-phosphate dehydrogenase 0.2 NADPH + H + 6-Phosphogluconolactone NAD+ 0 FIGURE 7–11 Coupled enzyme assay for hexokinase activity. 200 250 300 350 400 The production of glucose-6-phosphate by hexokinase is coupled to Wavelength (nm) the oxidation of this product by glucose-6-phosphate dehydrogenase in the presence of added enzyme and NADP+. When an excess of FIGURE 7–10 Absorption spectra of NAD+ and NADH. Densi- glucose-6-phosphate dehydrogenase is present, the rate of formation ties are for a 44-mg/L solution in a cell with a 1-cm light path. NADP+ of NADPH, which can be measured at 340 nm, is governed by the rate and NADPH have spectra analogous to NAD+ and NADH, respectively. of formation of glucose-6-phosphate by hexokinase. CHAPTER 7 Enzymes: Mechanism of Action 67 cascaes that trigger boo cotting, cot issoution, an opso- TABLE 7–1 Principal Serum Enzymes Used in Clinical nization of invaing microbes. Severa enzymes are reease Diagnosis into pasma foowing ce eath or injury. Whie these atter Serum Enzyme Major Diagnostic Use enzymes perform no physioogic function in pasma, they can serve as biomarkers, moecues whose appearance or eves Alanine aminotransferase (ALT) Viral hepatitis can assist in the iagnosis an prognosis of iseases an inju- Amylase Acute pancreatitis ries affecting specific tissues. The pasma concentration of an Ceruloplasmin Hepatolenticular degeneration enzyme or other protein reease consequent to injury may (Wilson disease) rise eary or ate, an may ecine rapiy or sowy. Cytopas- Creatine kinase Muscle disorders mic proteins ten to appear more rapiy than those from sub- ceuar organees. γ-Glutamyl transferase Various liver diseases Quantitative anaysis of the activity of reease enzymes or Lactate dehydrogenase Liver diseases other proteins, typicay in pasma or serum but aso in urine isozyme 5 or various ces, provies information concerning iagnosis, Lipase Acute pancreatitis prognosis, an response to treatment. Assays of enzyme activ- ity typicay empoy stanar kinetic assays of initia reaction β-Glucocerebrosidase Gaucher disease rates. Table 7–1 ists severa enzymes of vaue in cinica iag- Phosphatase, acid Prostate disease, including nosis. Note that these enzymes are not absoutey specific for cancer the inicate isease. For exampe, eevate boo eves of Phosphatase, alkaline Various bone disorders, prostatic aci phosphatase are associate typicay with pros- (isozymes) obstructive liver diseases tate cancer, but aso may occur with certain other cancers an ALT, alanine aminotransferase. noncancerous conitions. Interpretation of enzyme assay ata Note: Many of the above enzymes are not specific to the disease listed. must make ue aowance for the sensitivity an the iagnos- tic specificity of the enzyme test, together with other factors eicite through a comprehensive cinica examination that or ess of a preiminary iagnosis to permit initiation of appro- incues patient’s age, sex, prior history, an possibe rug use. priate therapy. The first enzymes use to iagnose MI were aspartate aminotransferase (AST), aanine aminotransferase (ALT), an actate ehyrogenase (LDH). Diagnosis using Analysis of Serum Enzymes Following LDH expoits the tissue-specific variations in its quaternary Tissue Injury structure (Figure 7–12). However, it is reease reativey An enzyme usefu for iagnostic enzymoogy shou be rea- sowy foowing injury. Creatine kinase (CK) has three tissue- tivey specific for the tissue or organ uner stuy, an shou specific isozymes: CK-MM (skeeta musce), CK-BB (brain), appear in the pasma or other fui at a time usefu for iag- an CK-MB (heart an skeeta musce), aong with a more nosis (the “iagnostic winow”). In the case of a myocaria optima iagnostic winow. As with LDH, iniviua CK infarction (MI), etection must be possibe within a few hours isozymes are separabe by eectrophoresis. Toay, assays of + – Lactate (Lactate) SH2 S (Pyruvate) dehydrogenase Heart A NAD+ NADH + H+ Normal B Reduced PMS Oxidized PMS Liver C Oxidized NBT Reduced NBT (colorless) (blue formazan) 5 4 3 2 1 FIGURE 7–12 Normal and pathologic patterns of lactate dehydrogenase (LDH) isozymes in human serum. Samples of serum were separated by electrophoresis. LDH isozymes were then visualized using a dye-coupled reaction-specific for LDH. Pattern A is serum from a patient with a myocardial infarct; B is normal serum; and C is serum from a patient with liver disease. Arabic numerals identify LDH isozymes 1 through 5. Electrophoresis and a specific detection technique thus can be used to visualize isozymes of enzymes other than LDH. 68 SECTION II Enzymes: Kinetics, Mechanism, Regulation, & Role of Transition Metals pasma CK eves are primariy use to assess skeeta musce bioogica “fingerprints” to hep trace the source of a sampe isorers such as Duchene muscuar ystrophy. of DNA to a specific iniviua. RFLP suffers from severa important imitations, the most critica of which was the Plasma Troponin Constitutes the requirement for reativey high quantities of DNA to empoy as substrates for the restriction enzymes. Toay, a ramaticay Currently Preferred Diagnostic Marker more sensitive set of moecuar iagnostic toos base on the for an MI polymerase chain reaction (PCR) have argey suppante Troponin is a compex of three proteins present in the contrac- RFLP anaysis. tie apparatus of skeletal an cardiac muscle but not in smooth muscle (see Chapter 51). Troponin eves in pasma typicay Medical Applications of the Polymerase rise for 2 to 6 hours after an MI, an remain eevate for 4 to 10 ays. Immunoogica measurements of pasma eves of Chain Reaction cariac troponins I an T thus provie sensitive an specific As escribe in Chapter 39, the poymerase chain reaction inicators of amage to heart musce. Since other sources of (PCR) empoys a thermostabe DNA poymerase an appro- heart musce amage aso eevate serum troponin eves, car- priate oigonuceotie primers to prouce thousans of copies iac troponins provie a genera marker of cariac injury. of a efine segment of DNA from a minute quantity of start- ing materia. PCR enabes meica, bioogica, an forensic scientists to etect an characterize DNA present initiay at Additional Clinical Uses of Enzymes eves too ow for irect etection. In aition to screening for Enzymes are empoye in the cinica aboratory to etermine genetic mutations, PCR can be use to etect pathogens an the presence an the concentration of critica metaboites. For parasites such as Trypanosoma cruzi, the causative agent of exampe, gucose oxiase frequenty is utiize to measure Chagas isease, an Neisseria meningitides, the causative agent pasma gucose concentration. Enzymes aso are empoye of bacteria meningitis, through the seective ampification of with increasing frequency for the treatment of injury an their DNA. isease. Exampes incue tissue pasminogen activator (tPA) or streptokinase for treatment of acute MI, an trypsin for treat- ment of cystic fibrosis. Intravenous infusion of recombinanty RECOMBINANT DNA PROVIDES prouce gycosyases can be use to treat ysosoma storage synromes such as Gaucher isease (β-gucosiase), Pompe AN IMPORTANT TOOL FOR isease (α-gucosiase), Fabry isease (α-gaactosiase A), Sy STUDYING ENZYMES isease (β-gucuroniase), an mucopoysacchariosis types I, Highy purifie sampes of enzymes are essentia for the stuy II, an VI—aso known as Hurer synrome (α-L-iuroniase), of their structure an function. The isoation of an inivi- Hunter synrome (iuronate 2-sufatase), an Maroteaux-Lamy ua enzyme, particuary one present in ow concentration, synrome (arysufatase B), respectivey. from among the thousans of proteins present in a ce can be extremey ifficut. By coning the gene for the enzyme of interest, it generay is possibe to prouce arge quantities of ENZYMES FACILITATE DIAGNOSIS its encoe protein in Escherichia coli or yeast. However, not OF GENETIC & INFECTIOUS a anima proteins can be expresse in their appropriatey foe, functionay competent form in microbia ces as these DISEASES organisms cannot perform certain posttransationa process- Many iagnostic techniques take avantage of the specific- ing tasks specific to higher organisms. In these instances, ity an efficiency of the enzymes that act on oigonuceoties options incue expression of recombinant genes in cuture such as DNA. Eary on restriction endonucleases emerge anima ce systems or by empoying the bacuovirus expres- as an important too for both cinica an forensic anayses. sion vector of cuture insect ces. For more etais concern- Restriction enonuceases, often referre to as restriction ing recombinant DNA techniques, see Chapter 39. enzymes, ceave oube-strane DNA at sites specifie by a sequence of four, six, or more base pairs cae restriction sites (see Chapter 39). If an iniviua bears a mutation or polymor- Recombinant Fusion Proteins Are phism that either eiminates or generates the restriction site Purified by Affinity Chromatography for one of the enonuceases being use, the number an size Recombinant DNA technoogy can aso be use to generate of the DNA fragments prouce on ceavage wi iffer from proteins specificay moifie to rener them reaiy purifie that of another iniviua. Such restriction fragment length by affinity chromatography. The gene of interest is inke to polymorphisms (RFLPs) can be use for prenata etection an aitiona oigonuceotie sequence that encoes a car- of eeterious mutations characteristic of hereitary isorers boxy or amino termina extension to the protein of interest. such as sicke ce trait, β-thaassemia, infant phenyketonuria, The resuting fusion protein contains a new omain taiore an Huntington isease. They aso can be use as moecuar to interact with an appropriatey moifie affinity support. CHAPTER 7 Enzymes: Mechanism of Action 69 GST T Enzyme an cataysis. For exampe, the inference that a particuar ami- noacy resiue functions as a genera aci can be teste by Plasmid encoding GST Cloned DNA repacing it with an aminoacy resiue incapabe of onating with thrombin site (T) encoding enzyme a proton. Ligate together RIBOZYMES: ARTIFACTS FROM THE RNA WORLD GST T Enzyme Cech Discovered the First Catalytic Transfect cells, add RNA Molecule inducing agent, then For many years after their iscovery it was assume that a break cells enzymes were proteins. However, whie examining the pro- Apply to glutathione (GSH) cessing of ribosoma RNA (rRNA) moecues in the ciiate affinity column protozoan Tetrahymena in the eary 1980s, Thomas Cech an his coworkers observe that processing of the 26S rRNA pro- Sepharose GSH GST bead T Enzyme ceee smoothy in vitro even in the tota absence of protein. They subsequenty trace the source of this spicing activity Elute with GSH, to a 413 bp cataytic segment of the RNA, which they terme treat with thrombin a ribozyme (see Chapter 36)—a iscovery that earne Cech a Nobe Prize. GSH GST T Enzyme Severa other ribozymes have since been iscovere. The vast majority catayze nuceophiic ispacement reactions FIGURE 7–13 Use of glutathione S-transferase (GST) fusion that target the phosphoiester bons of the RNA backbone. proteins to purify recombinant proteins. (GSH, glutathione.) In sma sef-ceaving RNAs, such as hammerhea or hepatitis eta virus RNA, the attacking nuceophie is water an the One popuar approach is to attach an oigonuceotie that resut is hyroysis. For the arge group I intron ribozymes, encoes six consecutive histiine resiues. The expresse “His the attacking nuceophie is the 3′-hyroxy of the termina tag” protein bins to chromatographic supports that contain ribose of another segment of RNA an the resut is a spicing an immobiize ivaent meta ion such as Ni2+ or C2+. This reaction. approach expoits the abiity of these ivaent cations to bin His resiues. Once boun, contaminating proteins are washe The Ribosome—The Ultimate off an the His-tagge enzyme is eute with buffers contain- Ribozyme ing high concentrations of free histiine or imiazoe, which compete with the poyhistiine tais for bining to the immo- The ribosome was the first exampe of a “moecuar machine” biize meta ions. Aternativey, the substrate-bining omain to be recognize. A massive compex comprise of scores of of gutathione S-transferase (GST) can serve as a “GST tag.” protein subunits an severa arge ribosoma RNA moecues, Figure 7–13 iustrates the purification of a GST-fusion pro- the ribosome performs the vitay important an highy com- tein using an affinity support containing boun gutathione. pex process of synthesizing ong poypeptie chains foowing The aition of an N-termina fusion omain may aso the instructions encoe in messenger RNA (mRNA) mo- hep inuce proper foing of the remainer of the recombi- ecues (see Chapter 37). For many years, it was assume that nant poypeptie. Most fusion omains aso possess a ceav- rRNAs paye a passive, structura roe, or perhaps assiste age site for a highy specific protease such as thrombin in the in the recognition of cognate mRNAs through a base pair- region that inks the two portions of the protein to permit its ing mechanism. It was thus somewhat surprising when it was eventua remova. iscovere that rRNAs were both necessary an sufficient for catayzing peptie synthesis. Site-Directed Mutagenesis Provides The RNA World Hypothesis Mechanistic Insights The iscovery of ribozymes has ha a profoun infuence on Once the abiity to express a protein from its cone gene has evoutionary theory. For many years, scientists ha hypothe- been estabishe, it is possibe to empoy site-directed muta- size that the first bioogic cataysts were forme when amino genesis to change specific aminoacy resiues by atering their acis containe in the primoria soup coaesce to form sim- coons. Use in combination with kinetic anayses an x-ray pe proteins. With the reaization that RNA cou both carry crystaography, this approach faciitates ientification of the information an catayze chemica reactions, a new “RNA specific roes of given aminoacy resiues in substrate bining Wor” hypothesis emerge in which RNA constitute the 70 SECTION II Enzymes: Kinetics, Mechanism, Regulation, & Role of Transition Metals first bioogic macromoecue. Eventuay, a more chemicay Many enzymes can be assaye spectrophotometricay by stabe oigonuceotie, DNA, supersee RNA for ong-term couping them to an NAD(P)H-epenent ehyrogenase. information storage, whie proteins, by virtue of their greater Assay of pasma proteins, incuing severa enzymes, ais chemica functiona group an conformationa iversity cinica iagnosis an prognosis. ominate cataysis. If one assumes that some sort of RNA- Restriction enonuceases faciitate iagnosis of genetic iseases protein hybri was forme as an intermeiate in the transi- by reveaing restriction fragment ength poymorphisms. tion from ribonuceotie to poypeptie cataysts, one nees The PCR ampifies DNA initiay present in quantities too to ook no further than the ribosome to fin the presume sma for anaysis. missing ink. Attachment of a poyhistiy, GST, or other “tag” to the N- or Why i not proteins take over a cataytic functions? C-terminus of a recombinant protein faciitates its purification Presumaby, in the case of the ribosome the process was both by affinity chromatography. too compex an too essentia to permit much opportunity for Not a enzymes are proteins. Severa ribozymes are known that possibe competitors to gain a footho. In the case of the sma can cut an respice the phosphoiester bons of RNA whie sef-ceaving RNAs an sef-spicing introns, they may repre- it is the RNA components of the ribosome that are primariy sent one of the few cases in which RNA autocataysis is more responsibe for catayzing poypeptie synthesis. efficient than eveopment of a new protein catayst. REFERENCES SUMMARY Appe FS, Sanova Y, Jaffe AS, et a: Cariac troponin assays: Guie Enzymes are efficient cataysts whose stringent specificity to unerstaning anaytica characteristics an their impact on extens to the kin of reaction catayze, an typicay, to the cinica care. Cin Chem 2017;63:73. stereochemistry of their substrates. Baumer ZT, Whitehea TA: The inner workings of an enzyme: A high-throughput mutation screen issects the mechanistic basis In many enzymes, the suite of chemica toos avaiabe to of enzyme activity. Science 2021;373:391. faciitate cataysis has been expane using non-amino aci Bishop ML, Foy EP, Schoeff, LE: Clinical Chemistry. Principles, moecues. When tighty boun, these inorganic an organic Techniques, and Correlations, 8th e. Jones & Bartett Learning, 2018. moecues are referre to as prosthetic groups. If oosey boun Frey PA, Hegeman AD: Enzyme Reaction Mechanisms. Oxfor (issociabe), they are referre to as cofactors. University Press, 2006. Coenzymes, many of which are erivatives of B vitamins, Heckman CM, Paraisi F: Looking back: A short history of the serve as “shuttes” for commony use groups such as amines, iscovery of enzymes an how they became powerfu chemica eectrons, an acety groups. too. Chem Cat Chem 2020;12:6082. During cataysis, enzymes reirect the conformationa changes Hestrom L: Serine protease mechanism an specificity. Chem Rev inuce by substrate bining to effect compementary changes 2002;102:4501. that faciitate transformation into prouct. Knight AE: Singe enzyme stuies: A historica perspective. Meth Mechanistic strategies empoye by enzymes to faciitate Mo Bio 2011;778:1. cataysis incue the introuction of strain, approximation of Rho JH, Lampe PD: High–throughput anaysis of pasma hybri reactants, aci–base cataysis, an covaent cataysis. markers for eary etection of cancers. Proteomes 2014;2:1. Sanabria H, Ronin D, Hemmen K, et a: Resoving ynamics an Aminoacy resiues that participate in cataysis are highy function of transient states in singe enzyme moecues. Nature conserve through the evoution of enzymes. Commun 2020;11:1231. The abiity to change resiues suspecte of being important Spies M, Chema Y (es): Single-Molecule Enzymology: Fluorescence- in cataysis or substrate bining by site-irecte mutagenesis based and High-throughput Methods. Methos Enzymo, vo. 581, provies important insights into mechanisms of enzyme action. Acaemic Press, 2016 (Entire voume). The cataytic activity of enzymes reveas their presence, Weinberg CA, Weinberg Z, Hammann C: Nove ribozymes: faciitates their etection, an provies the basis for enzyme- Discovery, cataytic mechanisms, an the quest to unerstan inke immunoassays. bioogica function. Nuc Acis Res 2019;47:9480.

Use Quizgecko on...
Browser
Browser